A2M and B-cell chronic lymphocytic leukemia: The binding of α2m-IgG hexamer complexes to the cell surface receptor GRP78 [128], a receptor mainly expressed on B cells, and upregulated in CLL patients (compared to healthy controls), occurred only in CLL patients, and lead to chronic activation of the complement system, reducing patients ability to clear malignant cells [129].